Smoking, Tobacco and Gutka — During Head and Neck Radiation

Yes. Continuing to smoke, chew tobacco or use gutka during head and neck radiation is linked to a weaker treatment response, according to NCCN and ASTRO patient-education guidance. Tobacco narrows blood vessels and lowers the oxygen reaching your tissues, and radiation relies on oxygen to damage cancer cell DNA effectively — this is described in radiobiology as the oxygen effect. Guideline bodies also associate continued tobacco use during head and neck radiation with poorer local tumour control and a higher chance of the cancer returning in the treated area. This is exactly why your care team will ask about your tobacco use honestly, and why quitting or cutting down is worth discussing regardless of how far into treatment you already are.

Yes, absolutely. Quitting tobacco at any point during radiation — even the day before your last sitting — still helps. It reduces the extra strain on tissue that is already inflamed from treatment, supports faster healing between sittings, and lowers your risk of complications and recurrence going forward from the moment you stop. This is especially relevant across Telangana and South India, where smokeless tobacco such as gutka and khaini is used at least as widely as cigarettes; the WHO has long identified South Asia as a region with a particularly high smokeless-tobacco burden. Quitting any form — smoked or smokeless — makes a real, measurable difference, not just cigarettes specifically.

You do not have to quit alone. Nicotine-replacement options such as patches, gum or lozenges can often be used alongside radiation under your care team's guidance, and certain prescription medicines that support quitting may also be considered after review by your treating doctor. Counselling and brief behavioural support sessions can be scheduled around your sitting timings, and free tobacco-cessation quitlines are available by phone for cigarette, gutka and khaini use alike. Family members and caretakers can also help by tracking cravings and cut-down progress without adding pressure. At CION, this support is arranged as part of your care — no separate appointment or judgement required.

Yes. Tobacco and gutka directly irritate tissue that radiation has already inflamed, which tends to make mucositis (mouth and throat soreness), dry mouth and swallowing pain more severe and slower to heal. If side effects become severe enough, your care team may need to briefly pause sittings to let the tissue recover — something continuing tobacco use makes more likely. Watch for red-flag signs that need a same-day call to your care team: inability to swallow liquids or your own saliva, bleeding from the mouth or throat, fever, or a mouth ulcer that has not started healing within about two weeks. Mild soreness and taste changes, by contrast, are expected and can usually be managed with your team's guidance.

No. Smokeless tobacco is not a safer swap during head and neck radiation. Gutka and khaini carry the same treatment-interference risk as smoking — the same reduced oxygen delivery that makes radiation less effective — and they add direct chemical and mechanical irritation to oral tissue that is already inflamed from treatment, since they sit against the gums, cheek or tongue for extended periods. This can make mouth sores, gum irritation and healing delays worse in the exact area being treated. If you currently use gutka or khaini instead of cigarettes, that is still tobacco use worth discussing with your care team, not a safer alternative to continue during treatment.

Yes, continue your radiation therapy regardless. Treatment is never withheld because of tobacco use, and this is not about achieving a perfect quit before your team will treat you. Cutting down, even without fully quitting, still reduces some of the extra strain on your tissue and is worth doing. Your radiation oncology team's job is to support you through treatment as you are, not to judge your tobacco or gutka use — being honest with them about it genuinely helps them plan your care and manage your side effects better. Your radiotherapy is delivered at an NABH-accredited partner centre, and CION coordinates your treatment plan, your oncology team and your care throughout, support included.